CN Patent

CN101910113A — 左旋多巴控释制剂及其用途

Assigned to Impax Laboratories LLC · Expires 2010-12-08 · 15y expired

What this patent protects

本发明提供左旋多巴(levodopa)控释口服固体制剂，其包含左旋多巴、脱羧酶抑制剂和羧酸。本发明还提供左旋多巴多颗粒控释口服固体制剂，其包含：i)控释组分，包含左旋多巴、脱羧酶抑制剂和速率控制赋形剂的混合物；ii)羧酸组分；和iii)速释组分，包含左旋多巴和脱羧酶抑制剂的混合物。

USPTO Abstract

本发明提供左旋多巴(levodopa)控释口服固体制剂，其包含左旋多巴、脱羧酶抑制剂和羧酸。本发明还提供左旋多巴多颗粒控释口服固体制剂，其包含：i)控释组分，包含左旋多巴、脱羧酶抑制剂和速率控制赋形剂的混合物；ii)羧酸组分；和iii)速释组分，包含左旋多巴和脱羧酶抑制剂的混合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101910113A
Jurisdiction
CN
Classification
—
Expires
2010-12-08
Drug substance claim
No
Drug product claim
No
Assignee
Impax Laboratories LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.